Skip Navigation

JNCI Journal of the National Cancer Institute 2000 92(8):590-591; doi:10.1093/jnci/92.8.590
© 2000 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Albertsen, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Albertsen, P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 92, No. 8, 590-591, April 19, 2000
© 2000 Oxford University Press

EDITORIAL

When Is a Death From Prostate Cancer Not a Death From Prostate Cancer?

Peter Albertsen

Correspondence to: Peter Albertsen, M.D., University of Connecticut Health Center, 263 Farmington Ave., Farmington, CT 06030-3955 (e-mail: Albertsen@nso.uchc.edu).

Since the advent of testing for prostate-specific antigen (PSA) more than a decade ago, the number of men diagnosed with prostate cancer has increased dramatically (1). Many of these men have been subjected to treatments, such as radical prostatectomy, radiation therapy, and, more recently, radioactive seed implantation. As these men age, a substantial number of them will also receive androgen ablation therapy through either luteinizing hormone-releasing hormone analogues or bilateral orchiectomy (2). This enormous diagnostic and treatment effort has been implemented on the basis of the . . . [Full Text of this Article]

REFERENCES


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Am. J. Roentgenol.Home page
L. Berlin
Liability for Failure to Order Screening Examinations
Am. J. Roentgenol., December 1, 2002; 179(6): 1401 - 1405.
[Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
W. C. Black, D. A. Haggstrom, and H. Gilbert Welch
All-Cause Mortality in Randomized Trials of Cancer Screening
J Natl Cancer Inst, February 6, 2002; 94(3): 167 - 173.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
C. C. Zielinski and M. Hejna
Warfarin for Cancer Prevention
N. Engl. J. Med., June 29, 2000; 342(26): 1991 - 1993.
[Full Text]